Blood Glucose Meter: Technology, Business Opportunity and Patent Analysis
June 15, 2015 / David Chen
30 Page, Topical Report
US$2,000 (Single User License)

Abstract

Amid the global economy growth, the number of consumers with diabetes is rising annually in several countries and regions as result of unhealthy diets with high sugar and calorie intakes. Having a blood glucose meter is evidenced to help diabetes patients effectively control blood glucose levels, thereby reducing the risk of complications associated with diabetes. This report provides an overview of invasive and non-invasive blood glucose meters and market outlook and the relative R&D strength analysis of top 30 companies; examines strategic and patent deployments of several established players in the industry such as Dexcom, Medtronic, Abbott, Baxter and Roche Diagnostics.
  •  Table of Contents
  •  List of Topics
  •  List of Figures
  •  List of Tables
  •  Companies covered
To get MIC's complete insight, please log in.